Studio Technologies Introduces New Model 385 Mic/Intercom Beltpack For Broadcast and Live-Event Audio Applications
SKOKIE, IL, JUNE 1, 2026 – Studio Technologies, a leading manufacturer of high-quality audio, video,
Marshall Electronics Powers Seamless AV Experiences With Scalable IP Camera Solutions
LAS VEGAS, JUNE 1, 2026 — Marshall Electronics is showcasing a comprehensive lineup of next-generation
Ainos Launches Smell AI Study at National Taiwan University Hospital for ER Overcrowding and Respiratory Infection Risk Analysis
AI Nose Expands from Semiconductor Facilities into Frontline Healthcare Infrastructure HOUSTON, TX / ACCESS Newswire
Rescue Intellitech Renews Partnership with The Fire Fighter Cancer Foundation to Advance Firefighter Health and Safety
MANASSAS, VA / ACCESS Newswire / June 1, 2026 / Rescue Intellitech, a leader in
RF Industries to Report Second Quarter Results on June 15
SAN DIEGO, CA / ACCESS Newswire / June 1, 2026 / RF Industries, Ltd, (NASDAQ:RFIL),
Datametrex AI Announces Completion Of Hilco Global Patent Portfolio Qualification Review
TORONTO, ON / ACCESS Newswire / June 1, 2026 / Datametrex AI Limited (the “Company”
Applied Energetics to Participate in the 2026 Morgan Stanley National Security Innovation Summit
TUCSON, AZ / ACCESS Newswire / June 1, 2026 / Applied Energetics, Inc. (OTCQB:AERG), a
Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASCO Annual Meeting
At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran
SpecDD Launches the Missing Context Layer for AI Coding
Internal tests showed up to 89% faster time to live when AI tools stopped guessing
American Rebel Holdings, Inc. (OTC:AREB) Proudly Announces American Rebel Light Beer – America’s Patriotic Beer – Is Now Available in Central Florida Through Wayne Densch, Inc.
Wayne Densch – Central Florida’s #1 Beer Distributor for Over 64 Years – Launched American
Sunshine Biopharma Announces Canadian Approval for Rivaroxaban, a Generic Form of Xarelto(R)
FORT LAUDERDALE, FL / ACCESS Newswire / June 1, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM)
Black Book to Release Highly Anticipated 2026 Vendor-Agnostic RCM KPI Results Ahead of HFMA Annual Conference 2026
Independent qualitative KPIs across 48 RCM categories will help healthcare buyers prove platform performance before
Wellgistics Health Provides Mid-Year 2026 Corporate Outlook
Focus is on closing DelivMeds AI transaction, driving pharmacy revenue growth and supporting PharmacyChain™, Medical
Riccio Pharmacy Online Pharmacy Delivery: What Patients Should Know
BENSALEM, PA / ACCESS Newswire / June 1, 2026 / Healthcare is becoming more digital
Eskay Mining Corp. announces First Targets in its 5,000 meter Drill Program on its Corey-Eskay Property in British Columbia’s Golden Triangle
TORONTO, ON / ACCESS Newswire / June 1, 2026 / Eskay Mining Corp. (“Eskay” or
KIDZ AI Enters Exclusive Co-Development Partnership with ICreate Education Technology to Launch AI-Native Robotics Learning Platform for North America
NEW YORK, NY / ACCESS Newswire / June 1, 2026 / KIDZ AI Inc. (NASDAQ:KIDZ)
SLAM Using New VTEM Survey To Generate Copper Nickel Cobalt Targets on the Goodwin Project
VTEM Survey Generating Critical Element Targets in the Mineral-Rich Province of New Brunswick, Canada MIRAMICHI,
Simon Arias Discusses Why Young Professionals Are Rejecting Traditional Career Paths
Simon Arias Discusses Why Young Professionals Are Rejecting Traditional Career Paths LOS ANGELES, CA /
Extreme Management Group: Extreme Metal Legends Cryptopsy Finish Headlining The 2026 Decibel Magazine Tour Across North America With A Record Amount Of Sold-Out Shows
The 21-date Decibel Magazine Tour, the longest-running heavy metal tour in North America, ran from
Protagonist Therapeutics to Present Phase 3 VERIFY and Long-Term Rusfertide Data at the 2026 European Hematology Association Congress
NEWARK, CA / ACCESS Newswire / June 1, 2026 / Protagonist Therapeutics, Inc. (“Protagonist” or